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a  b  s  t  r  a  c  t
We  previously  demonstrated  that  Cigarette  Smoke  (CS)  induces  autophagy  in  the  ovary.  Therefore  we
aimed  to determine  if chloroquine  (CQ)  could  inhibit  CS-induced  autophagy  in the  ovary.  Eight  week  old
mice were  implanted  with  CQ  pellets;  0,  25, and  50 mg  CQ/kg.  Half  of  the  animals  in each  group  were
exposed  to  room  air  and  the  other  half  were  exposed  to CS  twice  daily  for 8 weeks.  Ovaries  were  harvested
for  electron  microscopy,  gene  and  protein  expression  analysis.  There  was  a signiﬁcant  increase  in theeywords:
utophagy
igarette smoke
varian function
ell death
production  of autophagosomes  in granulosa  cells  of mice  exposed  to  CS  (p  = 0.0297).  However  25  and
50  mg/kg  CQ  treatment  signiﬁcantly  decreased  the CS-induced  autophagosomes  (p =  0.0505;  p  =  0.0065)
and  attenuated  the  effects  of  CS  on  LC3B  and BECN1  expression.  In summary,  this  suggests  that  CQ
attenuates  CS-induced  autophagy  in the  ovary  and  that  ovarian  protection  from  toxic  insult  is  potentially
feasible.
©  2016  The  Authors.  Published  by Elsevier  Inc. This  is an  open  access  article  under  the CC  BY-NC-ND. Introduction
Approximately 48.5 million couples worldwide struggle with
nfertility [1]. Of the many contributing factors investigated,
xposure to environmental contaminants is thought to be a poten-
ially important cause of infertility. Furthermore, exposure to
he environmental toxicants contained in cigarette smoke has
een documented to lower circulating concentrations of estradiol,
ecrease the rate of ovarian follicle development, increase folli-
le loss [2–7], and increase the frequency of reproductive failure
n women who smoke compared to non-smokers [4,8]. Cigarette
moke (CS) exposure has been shown to attenuate the response
o ovulation induction in women undergoing assisted reproduc-
ive therapies [9–13], and in utero exposure to CS has been shown
o signiﬁcantly affect human fetal development [14]. Sidestream-
moking (SS) is a type of second hand smoke that comes directly
rom a lit cigarette and thus exposes the non-smoker to harmful
arcinogens. SS is also known to be equally as harmful to fertility as
ainstream CS [15] and CS toxicants have been quantiﬁed in repro-
uctive tissues and ﬂuids of women who smoke at concentrations
reater than in the serum [16,17].
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/).license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Contrary to the existing dogma that ovarian follicle loss is medi-
ated via apoptosis, we  have shown that follicle loss in the ovary
is in fact mediated via autophagy. Our previous work highlighted
that CS-exposure increased the loss of ovarian follicles and initi-
ated autophagic signaling in ovarian granulosa cells [18,19]. More
recently we  demonstrated that CS exposure-induced autophagy
arose from both the activation of the pro-autophagic AMPK
pathway combined with the inhibition of two  anti-autophagic
markers, AKT and mTOR [20]. Moreover, two  positive regulators
of autophagy Beclin 1 (BECN1) and microtubule-associated protein
1A/1B-light chain 3 (LC3) [21,22], were signiﬁcantly over expressed
in CS-exposed ovaries compared to control mice [19].
Having shown that CS-induced follicle loss is primarily medi-
ated via activation of autophagy we  postulate that follicle loss can
thus be mitigated by inhibiting autophagy. Autophagy can be medi-
ated through (1) the application of pharmacological inhibitors or
(2) genetic intervention. In particular, anti-autophagic pharmaco-
logical interventions are currently being assessed for their efﬁcacy
as an adjunctive treatment to chemotherapy and radiotherapy.
Autophagic inhibitors include; (1) Balﬁlomycin A1, which inhibits
maturation of autophagosomes [23], (2) Chloroquine or Lys05,
which impairs autophagy through alkalization of the lysosomes, (3)
Pepstatin A and E64d, which suppress lysosomal proteases, and (4)
Leupeptin, which blocks the degradation steps of autophagy [24].
However, of these, chloroquine (CQ) and its derivative hydroxy-
chloroquine (HCQ) are the most clinically relevant and widely used
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.
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utophagic inhibitors. As CQ and HCQ are safe and effective anti-
alarial and anti-inﬂammatory therapies [25], HCQ was  therefore
hosen as the inhibitor for the current investigation. CQ was dis-
overed in 1934, but not utilised in medicine for many years as
t was believed to be toxic to humans. However since its discov-
ry, we now know that CQ is of low-toxicity to humans and widely
mployed as an anti-malarial drug. Additionally, it is an effective
nti-inﬂammatory agent used to treat rheumatoid arthritis [26].
Q accumulates in the lysosomes of cells, increasing the lysosomal
H and subsequently interfering with autophagosome degradation
26] during the late stages of the autophagic signaling pathway.
To evaluate the effects of CQ treatment on CS-induced ovar-
an autophagy, we used our well-established CS-exposed mouse
odel [20,27]. The goals of this study were as follows; (1) inves-
igate autophagic markers in the ovary of mice exposed to CS,
2) investigate the effect of CQ alone or in combination with CS
n autophagic signaling in the mouse ovary and (3) determine
hether CQ is capable of inhibiting autophagic signaling in mice
xposed to co-treatment of CS + CQ and determine which dose of
Q had the greater overall protective effect, if any.
. Materials and method
.1. Animals and ethics
All animal work in the present study was conducted using pro-
ocols approved by the McMaster Animal Research Ethics Board
nd was in accordance with the Canadian Council for Animal Care
uidelines for the use of animals in research. AUP: 14-07-24.
Brieﬂy, female C57BL/6 mice (8 weeks of age at the start of expo-
ure) were obtained from Charles River Laboratories. Mice were
aintained in polycarbonate cages at 22 ◦C ± 2 ◦C and 50% ± 10%
elative humidity on a 12 h light:12 h dark photoperiod and were
rovided with normal rodent chow (LabDiet; PMI Nutrition Inter-
ational) and tap water ad libitum throughout the experiment.
ice were divided into 6 treatment groups of 10 animals each as
ollows; CS ± CQ (0, 25 and 50 mg/kg).
.2. Hydroxychloroquine pellet design and subcutaneous
dministration
Treatment pellets were prepared using Elvax 40P resin beads
provided by Dupont, Canada, #MSDS 130000022269) as previ-
usly described [28,29]. The Elvax resin beads were dissolved in
H2Cl2 (dichloromethane), to give a 10%w/v solution during pellet
reparation. Chloroquine diphosphate salt (Sigma Aldrich, Oakville
ntario, Canada Cat No.: C6628) was dispersed in the solution and
ixed on a magnetic stirrer until the entire drug was  uniformly
issolved. The mixture was poured into plastic molds, and marked
recisely for cutting. The molds were initially stored at −20 ◦C and
fter 24 h stored at −80 ◦C. The plastic polymer mix  was cut accord-
ng to concentration required (1 mm3 in size). Individual implants
ere placed into labelled sterile tubes prior to surgical implanta-
ion into mice. The CQ pellets were surgically implanted in the nape
f the neck so that each animal received a pellet containing 0 (con-
rol), 25 or 50 mg/kg of CQ. The half-life of CQ is approximately 40
ays in humans [30].
All surgical procedures were carried out in compliance with the
urvival surgery guidelines outlined by the central animal facil-
ty at McMaster University, permitted by The Ontario Ministry of
griculture and Food and the Canadian Council of Animal Care.
rieﬂy, the animals were deemed healthy and fully anaesthetized
y isoﬂurane. They were subsequently prepared for surgery using
n aseptic scrub. The analgesic, Anafen (10 mg/ml) was  subcuta-
eously administered to the mice to control pain. Elvax pelletsxicology 61 (2016) 105–113
containing the HCQ or vehicle (95% ethanol) were implanted sub-
cutaneously in the scapular region of the back through a small
surgical incision under isoﬂurane anesthesia. The incisions were
sutured closed and monitored post-surgery. All animals survived
the surgery and there were no wound infections or other compli-
cations reported.
2.3. Cigarette smoke exposure
Cigarette smoke exposure was  initiated one week post-surgical
implantation of CQ pellets. Mice were exposed to cigarette smoke
twice daily, 5 days a week for 8 weeks using a whole-body
smoke exposure system (SIU48; Promech Lab AB). Details of the
smoke exposure protocol have been described previously in detail
[20,27,31]. Mice were euthanized at the end of the exposure period
with CO2, and ovaries were collected and weighed before process-
ing.
2.4. Transmission electron microscopy
Ovaries were collected and processed as follows; one from each
mouse for electron microscopy and one for RNA/Protein analysis,
as described previously [18–20]. Brieﬂy, ovaries were excised and
ﬁxed with 2% glutaraldehyde buffered in 0.1 M sodium cacody-
late buffer containing 0.05% calcium chloride (pH7.4) at 4 ◦C. Tissue
blocks from 10 mice per treatment group were sectioned (section
thickness, 75 m)  with a Sorvall TC-2 mictotome and postﬁxed in
1.5% ferrrocyanide reduced osmium tetroxide, followed by dehy-
dration in ethanol and inﬁltration in propylene oxide, and then
embedded in Epon (Miller-Stephenson Chemical Co., Inc.). Ovar-
ian tissue samples were randomly selected from each treatment
group and autophagosomes in granulosa cells were counted in
seven different ﬁelds of view per ovary at ×7500 magniﬁcation and
the average number of autophagosomes per mouse per treatment
group were calculated. Only granulosa cells with a visible nucleus
were counted. Autophagosomes were counted independently by
three observers blinded to treatment.
2.5. Quantitative real-time PCR
Total RNA and Protein were isolated from one ovary per
mouse using a total RNA/Protein puriﬁcation kit (NORGEN, Biotek
Corp, Thorold Ontario, Canada) as per manufacturer’s instruc-
tions and quantiﬁed by spectrophotometric analysis (Nanodrop).
cDNA was then reverse transcribed using an iScript kit (Bio-
Rad). Primers were designed using the online tools Primer3,
IDTDNA and OligoAnalyzer3.0 and primer products between 50
and 130 bp were selected for analysis. Murine-speciﬁc primers
were designed (Mobix Lab, Hamilton Ontario, Canada) and primer
pairs (SA Biosciences) were prepared (Table 1). PCR ampliﬁca-
tion was carried out in a 10 l reaction volume (7 l master mix)
containing 1 g/100 ng of cDNA (2.5 l), 1 l of forward and 1 l
reverse primers (Mobix Lab, Hamilton Ontario, Canada) or 10 M
of forward and reverse primers (SA Biosciences, Toronto Ontario,
Canada) with 5 l of SYBR Green Master Mix  (Roche, Mississauga
Ontario, Canada) and 2 l of ddH2O. Real-time PCR reactions were
carried out using the Roche LC480 instrument and the program
was set as follows: denaturation at 95 ◦C for 10 min, followed by 40
ampliﬁcation cycles of 95 ◦C for 15 s and 60 ◦C for 1 min. Samples
were run in duplicate and results were averaged. Relative quantiﬁ-
cation analysis was used to compare the levels of mRNA expression
across the controls (room-air and either 0, 25 and 50 mg/kg CQ pel-
lets) and between controls and smoke (CS and either 0, 25 and
50 mg/kg CQ pellets) mice using a housekeeper (reference) gene.
Multiple reference genes were considered for normalization but
the reference gene Actb was selected for analysis as it was constitu-
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Table  1
List of forward and reverse primer sequences used for qPCR analysis [18].
Gene Left primer (Forward) Right primer (Reverse) Product size % GC content Melting point (◦C)
CTAT
TGTA
945B-
t
R
r
2
h
p
t
b
(
7
a
t
a
w
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s
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w
d
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m
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2
w
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oBeclin-1 CCAGCCAGGATGATGTCTAC CCCGATCAGAGTGAAG
Lc3b  CACTCCCATCTCCGAAGTGTA TGCGAGGCATAAACCA
Actb  CAT NUMBER: PPM02945B-200 CAT NUMBER: PPM02
ively expressed and did not change under all treatment conditions.
esults are presented as the mean normalized ratios of the internal
eference gene.
.6. Western blot analysis
Protein expression was measured from the whole ovarian
omogenates isolated from the mice using the total RNA/Protein
uriﬁcation kit as described above. Brieﬂy, following SDS-PAGE and
ransfer to PVDF membrane (BioRad, Canada), membranes were
locked overnight with 5% (w/v) skim milk in Tris-buffered saline
TBS; 8 g/l [w/v] NaCl, 0.2 g/l [w/v] KCl, and 3 g/l [w/v] Tris base; pH
.4) with Tween-20 (TBS-T; 1 × TBS and 0.5% [v/v] Tween-20) or
 blocking solution of 5% BSA:TBS-T (depending on the manufac-
urer’s instructions for the antibody) and incubated with primary
ntibody at 4 ◦C overnight. The following antibodies and dilutions
ere used for the present study: Beta-actin (ACTB; 1:5000; Abcam),
eclin-1 (BECN1; 1:1000; CST) and microtubule-associated protein
 light chain 3 (LC3B; 1:2000; Novus). Following washing with TBS-
, blots were incubated with horseradish peroxidase-conjugated
econdary anti-rabbit immunoglobulin (Ig) (1:4000; Amersham
iosciences) or anti-mouse IgG (1:4000; Amersham Biosciences)
ntibodies for 1 h at room temperature. Blots were thoroughly
ashed in TBS-T followed by TBS, whereupon reactive protein was
etected using ECL Plus chemiluminescence substrate (Amersham
iosciences) and Bioﬂex X-ray ﬁlm (Clonex Corporation). Densito-
etric analysis of immunoblots was performed using Image J 1.37v
oftware (National Institutes of Health); all proteins were quanti-
ed relative to the loading control ACTB.
.7. Statistical analysisStatistical differences were assessed using GraphPad Prism soft-
are. Data were initially checked for normality by applying a
’Agostino & Pearson omnibus normality test, followed by either a
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one-way ANOVA for comparison across the three treatment groups
(0, 25, or 50 mg/kg), followed by either a T-Test (normally dis-
tributed data) or a Mann-Whitney (non-normally distributed data)
test. The qPCR results are presented as normalized mean ratios and
±SEM of the target:reference gene. Representative Western blot
results are shown and ACTB was used as the loading control. A p
value of 0.05 was  considered signiﬁcant for all statistical compar-
isons.
3. Results
3.1. Animal health
Treatment with CS had no effect on the general health of the
mice, as shown by absence of stereotypical behaviors of smoking
mice [19], hunched back and signs of lacrimation, porphyria, or ruf-
ﬂed coat. In mice exposed to 8 weeks of whole body CS exposure
the body weight and relative ovarian weights were lower as com-
pared with sham, room-air exposed controls. This was consistent
with our previous investigation [18].
3.2. Cigarette smoke induces body-weight changes in mice
There was  no effect of CQ (25 and 50 mg/kg), on body weight
in control (room-air exposed) mice (Fig. 1A). However, in mice
exposed to 8 weeks of CS the whole body weights were 16% and
signiﬁcantly lower than in the control group exposed to room
air (0 mg/kg CQ; p <0.0001) (Fig. 1B). Additionally, smoke-exposed
mice implanted with a 25 mg/kg CQ pellet revealed a 5% increase
in body weight and the 50 mg/kg CQ pellet treated mice revealed
a 7% signiﬁcant increase in bodyweight compared to mice exposed
to CS only (p = 0.0276; Fig. 1C).
The ovarian weights were measured relative to body weight.
Relative ovarian weight was unaffected by CQ treatment (Fig. 2A).
The data revealed a trend towards a decrease in relative ovarian
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Fig. 2. Weight of ovary relative to body weight. Chloroquine containing pellets of either 0 mg/kg, 25 mg/kg or 50 mg/kg doses) were implanted in the nape of the mouse
neck,  and animals were exposed to cigarette smoke for 8 weeks. Mice were weighed at sacriﬁce to determine whether chloroquine and cigarette smoke treatment affected
ovarian weight. (A) Ovary weights of mice from the 0 mg/kg, 25 mg/kg and 50 mg/kg of chloroquine + no smoke treatment groups, (B) ovary weights of mice from the
0  mg/kg chloroquine + no smoke and mice from the 0 mg/kg chloroquine + smoke treatment groups. (C) Ovary weights of mice from the 0 mg/kg, 25 mg/kg and 50 mg/kg
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moke  exposed mice have smaller ovaries relative to body size. Each treatment gr
ere  deemed to be statistically signiﬁcant. Values are expressed as mean ± SEM. *P
eight in the CS-exposed mice, although not statistically signiﬁ-
ant (p = 0.0941; Fig. 2B). Similarly, there was a 160% increase of
elative ovarian weight in CS-exposed mice which were treated
ith 50 mg/kg CQ that verged on signiﬁcance (p = 0.0551; Fig. 2C).
.3. Cigarette smoke increases the quantity of autophagosome
ormation
Nuclei in the CS-exposed granulosa cells was displaced by
utophagosomes (Fig. 3D). Additionally, autophagosomes were
ore abundant in granulosa cells of ovaries from the CS-exposed
ice compared to room-air exposed controls. There was a low
bundance of autophagosomes and no statistically signiﬁcant dif-
erence between the 0, 25, and 50 mg/kg CQ groups which were
xposed to room-air only (Fig. 3A–C and G). However, in mice
xposed to CS, there was a statistically signiﬁcant increase in
utophagosomes as compared to the room-air exposed control
p = 0.0297; Fig. 3D and H). While the 25 mg/kg CQ treatment
nduced a partial decrease (p = 0.0505), mice treated with 50 mg/kg
Q had a signiﬁcant decrease in the number of CS-induced
utophagosomes (p = 0.0065) as compared to the 0 mg/kg treat-
ent in CS-exposed mice, highlighting a protective function of CQ
gainst CS-induced autophagosomes (Fig. 3E, 3F and I).
.4. Cigarette smoke activates the autophagic cascade whereas
hloroquine attenuates autophagy
.4.1. BECN1
Real-time PCR and Western blot analysis were performed on
he extracted RNA (cDNA) and protein from the ovaries of the mice
o make comparisons between gene and protein expression of the
utophagic markers Beclin1 (BECN1) and Lc3b (LC3B). The changes
n expression of each gene and protein were measured as a ratio, rel-
tive to the internal housekeeping gene Actb (ACTB). CQ treatment
ad no signiﬁcant effect on Beclin1 gene expression compared to the
ontrol group (Fig. 4A). CS-exposure had no effect on Beclin1 mRNAvaries. Relative ovarian weights of smoke exposed and control mice indicate that
 = 10. One way-ANOVA and Student’s T-Tests were carried out and values p < 0.05
, **P  < 0.01 and ***P < 0.001.
expression (p = 0.4657; Fig. 4B). Similarly, Beclin1 gene expression
was comparable in CS-exposed groups treated with CQ as compared
with the 0 mg/kg controls (p = 0.3298 p = 0.3049; Fig. 4C).
In the absence of CS, western blot analysis showed no signiﬁ-
cant changes in BECN1 expression between CQ treatment groups
(Fig. 4D). However, BECN1 was  signiﬁcantly increased in the CS-
exposed group in comparison to the control group exposed to room
air (p = 0.0015; Fig. 4E). Interestingly, the CS-expose mice treated
with 25 mg/kg CQ had a signiﬁcant decrease in BECN1 expression
(p = 0.0334) while those treated with 50 mg/kg CQ did not have a
statistically signiﬁcant decrease of BECN1 (p = 0.0902; Fig. 4F).
3.4.2. LC3B
In both CS-exposed and room air exposed mice, there was no
effect of CQ treatment on Lc3b expression (Fig. 5A, B). However,
further analysis of the CS-exposed groups revealed a signiﬁcant
decrease of Lc3b mRNA in response to 25 and 50 mg/kg CQ treat-
ment; (p = 0.0483 and p = 0.0347; Fig. 5C).
LC3B protein expression was  measured in CQ-treated groups
in the absence of CS and no statistically signiﬁcant changes were
observed (Fig. 5D). While LC3B expression increased in the CS-
exposed group as compared to mice exposed to room air and
trended toward statistical signiﬁcance (p = 0.0583; Fig. 5E), there
was a signiﬁcant decrease in LC3B expression in CS-exposed mice
treated with 50 mg/Kg CQ (p = 0.0413; Fig. 5F) as compared to CS-
exposed controls (0 mg/kg).
4. Discussion
In the current study, we examined the effects of the autophagic
inhibitor chloroquine (CQ) on CS-induced autophagy in the ovary
of adult mice. While mice exposed to CS showed an increase in the
number of autophagosomes in the ovarian granulosa cells, which is
harmonious with our previous work [19], CQ treatment attenuated
CS-induced autophagy. Moreover, expression of autophagic mark-
ers were decreased in the mice exposed to CS and treated with 25
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Fig. 3. Transmission electron microscopy revealed that autophagosomes are present in the granulosa cells of ovarian follicles exposed to cigarette smoke. Representative
transmission-electron micrographs of granulosa cells from antral follicles are shown, (A) 0 mg/kg Chloroquine, (B) 25 mg/kg Chloroquine, (C) 50 mg/kg Chloroquine, (D)
0  mg/kg chloroquine + cigarette smoke, (E) 25 mg/kg chloroquine + cigarette smoke and (F) 50 mg/kg chloroquine + cigarette smoke exposed ovaries are shown. Nuclei (N)
appear  normal but are displaced by autophagosomes (Au) in smoke-exposed ovaries. Original magniﬁcation is ×7500. The incidence of autophagosomes in the granulosa cells
o  and 5
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e
of  smoke-exposed ovaries are shown in the following groups (G) 0 mg/kg, 25 mg/kg
moke  and 0 mg/kg chloroquine + smoke treatment groups (I) 0 mg/kg, 25 mg/kg 
P  < 0.05, and **P < 0.01.
r 50 mg/kg CQ. Lower numbers of autophagosomes coupled with
 greater body weight compared to the smoke exposed 0 mg/kg
Q group suggests that CQ attenuates CS-induced autophagy and
ffers the prospect of ovarian protection from toxic insult.
Herein we demonstrated that CS exposure alone induced an
ncrease in the number of autophagosomes in ovarian granulosa
ells compared to control animals that were only exposed to room
ir. These results are congruent with our prior studies [18,19]. How-
ver, in contrast to our previous studies, CS had no effect on Beclin1
r Lc3b gene expression whilst BECN1 and LC3B protein expression0 mg/kg of chloroquine + no smoke treatment groups, (H) 0 mg/kg chloroquine + no
0 mg/kg of chloroquine + smoke treatment groups. Each treatment group; n = 10.
was increased compared to room air + 0 mg/kg CQ control group.
Divergent results in Beclin1 and Lc3b mRNA expression between
this and our prior studies are most likely the result of high variation
in expression.
CS exposure activates oxidative stress measured by increased
Hsp25 and decreased superoxide dismutase 2 protein expression
[18]. More speciﬁcally, CS exposure triggers antral follicle destruc-
tion and increased oocyte dysfunction through oxidative stress
[32] causing increased ovarian follicle loss in the mouse [18,19,33]
coupled with activated autophagy. It was previously thought that
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Fig. 4. Changes in Beclin1 gene expression was performed on whole-ovarian homogenates from the cigarette smoke and chloroquine exposed mice. Panel (A–C) show qPCR
g  show
c  were
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sene  expression changes relative to the actb control (n = 10 per group). Panel (D–F)
hanges relative to the ACTB loading control (n = 10 for each treatment group). Data
-test.  Values are expressed as mean ± SEM. *P < 0.05 and **P  < 0.01.
poptosis played a role in CS-induced oxidative stress leading to
varian follicle loss, however the pro-survival marker Bcl-2 was
hown to increase [33], and further investigations revealed a role
or the alternative cell-death pathway, autophagy [19]. The same
tudy revealed increases in autophagic markers, BECN1 and LC3B representative immunoblots and graphs demonstrating BECN1 protein expression
 checked for normality and equal variance, and treatment effects were tested using
and increased production of autophagosomes. LC3B can have either
an anti-apoptotic role in healthy cells or a pro-apoptotic role dur-
ing CS exposure [34]. The activation of CS-induced autophagy in the
ovary was recently shown to be activated through enhancement of
AMPK [20]. Similarly, exposure to particulate matter (PM2.5) can
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F nates
g ) show
c  were
T
i
i
n
c
a
t
(ig. 5. Changes in Lc3b gene expression was performed on whole-ovarian homoge
ene  expression changes relative to the actb control (n = 10 per group). Panel (D–F
hanges relative to the ACTB loading control (n = 10 for each treatment group). Data
-test.  Values are expressed as mean ± SEM. *P < 0.05.
nstigate AMPK mediated autophagy in cell culture [35]. Thus, tox-
cant induced changes in autophagy are not unique to the ovary
or to CS exposure, suggesting that activation of autophagy is a
ommon step in the pathway to toxic phenotypes. CS-induced
utophagy has been shown in the lung and believed to contribute
o the development of chronic obstructive pulmonary disease
COPD), [36–39] and thus is a potential target for disease therapy. from the cigarette smoke and chloroquine exposed mice. Panel (A–C) show qPCR
 representative immunoblots and graphs demonstrating LC3B protein expression
 checked for normality and equal variance, and treatment effects were tested using
Clinical studies investigating COPD have revealed a role for CS-
induced oxidative damage coupled with mitochondrial associated
autophagy [40]. CS-induced autophagy is believed to be selected
over apoptosis as an adaptation to cellular stress, which is perhaps
why the pathway is implicated in many cancers; as a result of apop-
totic resistance [41,42]. Autophagy can contribute to the survival
of dormant tumor cells instigating protection from chemotherapy
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nd radiotherapy and subsequent tumor resistance [43]. Chemi-
al inhibition of autophagy may  therefore inhibit the growth of
he tumor in question yielding therapeutic beneﬁt [44]. Therefore,
e postulate that therapeutic disruption of autophagy is a poten-
ial target that may  provide protection from CS or other chemical
oxicant-induced damage.
In the present study, mice treated with CQ pellets implanted
rior to CS exposure had a decreased number of autophagosomes
n their ovarian granulosa cells as compared to mice treated with
 mg/kg CQ which was also CS exposed. Furthermore, co-treatment
ith CQ and CS attenuated BECN1 and LC3B protein expression
ut not gene expression. CQ is a known inhibitor of autophagy and
cts through its accumulation in the lysosomes, which increases
he lysosomal pH and subsequently interferes with autophago-
ome degradation in the lysosomes [26]. Accordingly, inhibition
f autophagy may  either promote or inhibit cell death, which is
ltimately dependent on the cell conditions at the time and the
amaging agents a cell is exposed. CQ is able to inhibit cell prolif-
ration and induce cell death in CT26 mouse colon ﬁbroblast cells
n vitro, results that were repeated in vivo indicative of the poten-
ial chemotherapeutic relevance of CQ [45]. Tissue uptake of CQ as
 function of dosage is non-linear and CQ is metabolised through
he kidneys (40–60%), excreted in feces (8–25%), sloughed off the
kin (5%) and stored long term in lean body tissues (25–45%). Cells
re known to utilise the process of autophagy to maintain cellular
omeostasis, and so inhibition of autophagy through CQ sensi-
izes cells/tissues to treatment [46]. Therefore there are limitations
ssociated with CQ therapeutic treatment including the potential
dverse effects on normal cellular processes. Furthermore, the half-
ife of CQ is between 30 and 60 days [47], which substantiated
he CS exposure period chosen for the current study. However, CQ
ould be metabolised at a faster rate in mice, and could therefore
ccount for lack of effect at lower doses administered in the cur-
ent study. Alternative methods for ovarian protection including
argeted inhibition of aryl hydrocarbon receptor (AhR) activation,
hich occurs upstream of autophagy, have been considered. The
ffects of AhR ligand and CS constituent, benzo[a]pyrene was exam-
ned in isolated rat follicle cultures in vitro coupled with assessment
f the effects of the AhR antagonist resveratrol, and revealed some
romise for ovarian protection [3]. However, resveratrol functions
t multiple molecular target sites and therefore lack of speciﬁcity
or the autophagy pathway, was not considered further for the cur-
ent study.
In summary, in the current investigation we demonstrated that
Q treatment attenuated some effects of CS on the autophagic
arkers LC3B and BECN1 which are upstream of autophagy, and
ould potentially protect the ovary from CS-induced autophagic
ignalling and ovarian follicle loss. The therapeutic beneﬁts of CQ
re well deﬁned in other disease models; however, this study
xpands the literature elucidating beneﬁcial effects of CQ in atten-
ating CS-induced autophagy in the ovary. Therefore, we suggest
hat ovarian protection from toxic insults may  be achieved through
nterference with the autophagy cascade although the effects on
ertility preservation have yet to be demonstrated.
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